Gerbaldo H, Fickinger M P, Wetzel H, Helisch A, Philipp M, Benkert O
Department of Psychiatry, University of Mainz, F.R.G.
J Psychiatr Res. 1995 Jul-Aug;29(4):297-302. doi: 10.1016/0022-3956(95)00013-u.
Primary enduring negative symptoms (PENS) were studied in 26 patients with DSM-III-R schizophrenia and in 94 patients with unipolar major depressive episodes 5 years after the index episode. PENS were assessed with the Schedule for Deficit Syndrome (SDS). Negative symptoms were also assessed with the Scale for Assessment of Negative Symptoms (SANS) and subclassified into primary and secondary according to the SDS. The frequency of PENS did not differ significantly between schizophrenics and non-schizophrenic patients. Enduring negative symptoms (regardless of whether primary or not) were more frequently observed in schizophrenia (65% according to the SDS, and 88% according to the SANS) than in patients who had major depressive episodes (29% according to the SDS and 32% according to the SANS). By applying the SDS criteria for PENS, their frequency decreased in a manner which would probably affect the availability of patients samples for testing antinegative drugs. The results suggest that neither the negative symptomatology nor the primary enduring subtype ("deficit") is specific for schizophrenia. This finding might imply potential advantages of non-nosological, functional approaches for research into PENS.
在26例符合《精神疾病诊断与统计手册》第三版修订版(DSM-III-R)精神分裂症诊断标准的患者以及94例单相重度抑郁发作患者在索引发作5年后,对其原发性持久性阴性症状(PENS)进行了研究。采用缺陷综合征评定量表(SDS)评估PENS。还使用阴性症状评定量表(SANS)评估阴性症状,并根据SDS将其分为原发性和继发性。精神分裂症患者与非精神分裂症患者之间PENS的发生率无显著差异。与单相重度抑郁发作患者(根据SDS为29%,根据SANS为32%)相比,精神分裂症患者中更常观察到持久性阴性症状(无论是否为原发性,根据SDS为65%,根据SANS为88%)。按照SDS对PENS的标准进行应用,其发生率降低,这可能会影响用于测试抗阴性症状药物的患者样本的可获得性。结果表明,阴性症状学及原发性持久性亚型(“缺陷型”)均非精神分裂症所特有。这一发现可能意味着在PENS研究中采用非疾病分类学的功能性方法具有潜在优势。